Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

被引：35

作者：

da Silva, Elizabeth Nicole ^{[1
,2
]}

Randall, Katrina Louise ^{[1
,2
]}

机构：

[1] Canberra Hosp, Dept Immunol, Canberra, ACT, Australia

[2] Australian Natl Univ, Sch Med, Canberra, ACT, Australia

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2013年 / 1卷 / 06期

关键词：

D O I：

10.1016/j.jaip.2013.07.004

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：687 / 688

页数：2

共 50 条

[31] The efficacy and safety of allergen immunotherapy in patients with mast cell disorders and hymenoptera venom anaphylaxis
Salehi, C.
Jarkvist, J.
Nilsson, G.
Akin, C.
Gulen, T.
ALLERGY, 2018, 73 : 69 - 69
[32] DETAILED IGG AND IGE ANTIBODY PATTERNS DURING IMMUNOTHERAPY WITH HONEY-BEE VENOM
UHLIN, T
NORDVALL, SL
OHMAN, S
EINARSSON, R
ALLERGY, 1987, 42 (03) : 222 - 229
[33] Successful use of omalizumab for prevention of anaphylaxis in a patient with non-clonal mast cell activation and postural tachycardia syndrome
Chan, S.
Denman, S.
Savic, S.
CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (12): : 1634 - 1634
[34] Bee venom allergy immunotherapy/omalizumabIdiopathic non-clonal mast cell activation syndrome, pre-syncopal symptoms and bradycardia: case report
Reactions Weekly, 2020, 1785 (1) : 107 - 107
[35] OMALIZUMAB ASSOCIATED WITH DECREASED TRYPTASE LEVELS IN MAST CELL ACTIVATION SYNDROME
Trogen, B.
Parikh, P.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S96 - S96
[36] Double-blind placebo-controlled study on premedication with levocetirizine during ultrarush bee venom immunotherapy:: effects on efficacy and safety
Mueller, U.
Steiner, U.
Reimers, A.
Kriegel, C.
Huber, C.
Haeberli, G.
SWISS MEDICAL WEEKLY, 2007, 137 : 14S - 14S
[37] Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review
Sabato, Vito
Michel, Moise
Blank, Ulrich
Ebo, Didier G.
Vitte, Joana
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (05) : 426 - 434
[38] Recurrent uncommon presentation of anaphylaxis in a patient with mast cell activation syndrome
Courcol, J.
Dissanayake, G.
Ncomanzi, D.
ANAESTHESIA, 2021, 76 : 114 - 114
[39] SCITING TO A HALT: A CASE OF MAST CELL ACTIVATION SYNDROME AND RECURRENT ANAPHYLAXIS
Ariza, J.
Gada, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S111 - S111
[40] Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis
Sara Micaletto
Kurt Ruetzler
Martin Bruesch
Peter Schmid-Grendelmeier
Allergy, Asthma & Clinical Immunology, 18

← 1 2 3 4 5 →